a pharmacist
(EC) randomized participants to blocks of eight to the
CRM group or to the placebo group according to a predetermined
ratio of 1 : 1. Randomization codes were not
decoded until the end of follow-up, 23 June 2010, to
ensure double-blinding during all parts of the trial,
including the follow-up. Participants were compensated
for their travelling expenses